CC
CL icon

Curian Capital’s Colgate-Palmolive CL Stock Holding History

Curian Capital’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-24,342
Closed -$1.62M – 71
2015
Q4 		$1.62M Sell
24,342
-42,160
-63% -$2.8M 0.12% 183
2015
Q3 		$4.22M Sell
66,502
-27,866
-30% -$1.82M 0.11% 201
2015
Q2 		$6.17M Sell
94,368
-5,133
-5% -$348K 0.1% 218
2015
Q1 		$6.9M Sell
99,501
-2,339
-2% -$162K 0.12% 204
2014
Q4 		$7.05M Sell
101,840
-1,775
-2% -$120K 0.12% 200
2014
Q3 		$6.76M Sell
103,615
-1,458
-1% -$96.2K 0.12% 203
2014
Q2 		$7.16M Buy
105,073
+739
+0.7% +$49.5K 0.13% 197
2014
Q1 		$6.77M Sell
104,334
-8,813
-8% -$555K 0.12% 196
2013
Q4 		$7.38M Buy
113,147
+2,957
+3% +$189K 0.13% 176
2013
Q3 		$6.53M Buy
110,190
+1,475
+1% +$87.4K 0.12% 174
2013
Q2 		$6.23M Buy
+108,715
New +$6.45M 0.11% 170

Other funds holding CL

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Curian Capital's CL Position: Q1 2016 in Review

Curian Capital sold out of Colgate-Palmolive (CL) in Q1 2016, closing a stake of 24,342 shares — an estimated $1.62M sold.

Curian Capital first reported a position in CL in Q2 2013 and held it in 11 quarters. The position peaked at $7.38M in Q4 2013. 1,262 funds tracked by Wall St. Rank hold CL as of Q1 2016.

  • Curian Capital reported no remaining Colgate-Palmolive position as of Q1 2016 after selling out during the quarter.
  • Curian Capital sold 24,342 Colgate-Palmolive shares in Q1 2016, an estimated $1.62M.
  • Curian Capital first reported a position in Colgate-Palmolive in Q2 2013 and held it in 11 quarters.
  • Curian Capital's Colgate-Palmolive position peaked at $7.38M in Q4 2013.
  • 1,262 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2016.

Based on Curian Capital's 13F filing for Q1 2016.